Oncoplastic surgery in the treatment of breast cancer: a review of evolution and surgical training.

IF 2.1 4区 医学 Q3 ONCOLOGY
Francisco Pimentel Cavalcante, Felipe Pereira Zerwes, Eduardo Camargo Millen, André Mattar, Marcelo Antonini, Fabrício Palermo Brenelli, Antonio Luiz Frasson, René Aloisio da Costa Vieira
{"title":"Oncoplastic surgery in the treatment of breast cancer: a review of evolution and surgical training.","authors":"Francisco Pimentel Cavalcante, Felipe Pereira Zerwes, Eduardo Camargo Millen, André Mattar, Marcelo Antonini, Fabrício Palermo Brenelli, Antonio Luiz Frasson, René Aloisio da Costa Vieira","doi":"10.21037/cco-24-140","DOIUrl":null,"url":null,"abstract":"<p><p>Oncoplastic breast surgery (OBS) has undergone significant advancement in recent decades, transforming breast cancer (BC) treatment by facilitating increased rates of breast-conserving surgery (BCS) through volume displacement techniques and enabling immediate reconstruction via volume replacement following mastectomy. This approach has demonstrably improved cosmetic outcomes and health-related quality of life metrics for patients undergoing oncological intervention. The progression of surgical methodology from Halsted's radical mastectomy to contemporary oncoplastic techniques constitutes a fundamental paradigm shift in surgical approach. Meta-analyses and prospective cohort studies have established that oncoplastic techniques maintain oncological safety when compared with conventional BCS and mastectomy, demonstrating comparable local recurrence (LR) rates and disease-free survival (DFS) outcomes. Multiple classification systems for oncoplastic procedures have been established based on quantifiable metrics including percentage of breast volume resected, surgical complexity indices, and technical approach parameters, providing evidence-based frameworks for clinical decision-making. The breast surgeon currently functions as the critical nexus in multidisciplinary treatment of BC, integrating optimized surgical techniques with multimodal treatment protocols, particularly systemic therapeutic agents. The implementation of neoadjuvant chemotherapy (NCT) regimens has expanded the indications for breast conservation in cases previously requiring mastectomy, leading to the development of the \"extreme oncoplasty\" concept for selected patients. Nevertheless, significant implementation barriers persist globally, predominantly related to educational infrastructure limitations and the absence of standardized oncoplastic surgical training curricula for breast surgeons. Diverse training methodologies have emerged internationally, including simulation-based learning, subspecialty fellowships, and curricular integration in surgical residency programs, though outcome-based standardization remains elusive. This non-systematic review analyzes the developmental trajectory of breast cancer surgery, examining the evolution and validation of oncoplastic techniques, standardized classification systems, applications in challenging clinical scenarios, and the current status of surgical education, emphasizing the pivotal role of professional societies in developing evidence-based educational initiatives to broaden access to these advanced surgical techniques.</p>","PeriodicalId":9945,"journal":{"name":"Chinese clinical oncology","volume":"14 2","pages":"20"},"PeriodicalIF":2.1000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese clinical oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/cco-24-140","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Oncoplastic breast surgery (OBS) has undergone significant advancement in recent decades, transforming breast cancer (BC) treatment by facilitating increased rates of breast-conserving surgery (BCS) through volume displacement techniques and enabling immediate reconstruction via volume replacement following mastectomy. This approach has demonstrably improved cosmetic outcomes and health-related quality of life metrics for patients undergoing oncological intervention. The progression of surgical methodology from Halsted's radical mastectomy to contemporary oncoplastic techniques constitutes a fundamental paradigm shift in surgical approach. Meta-analyses and prospective cohort studies have established that oncoplastic techniques maintain oncological safety when compared with conventional BCS and mastectomy, demonstrating comparable local recurrence (LR) rates and disease-free survival (DFS) outcomes. Multiple classification systems for oncoplastic procedures have been established based on quantifiable metrics including percentage of breast volume resected, surgical complexity indices, and technical approach parameters, providing evidence-based frameworks for clinical decision-making. The breast surgeon currently functions as the critical nexus in multidisciplinary treatment of BC, integrating optimized surgical techniques with multimodal treatment protocols, particularly systemic therapeutic agents. The implementation of neoadjuvant chemotherapy (NCT) regimens has expanded the indications for breast conservation in cases previously requiring mastectomy, leading to the development of the "extreme oncoplasty" concept for selected patients. Nevertheless, significant implementation barriers persist globally, predominantly related to educational infrastructure limitations and the absence of standardized oncoplastic surgical training curricula for breast surgeons. Diverse training methodologies have emerged internationally, including simulation-based learning, subspecialty fellowships, and curricular integration in surgical residency programs, though outcome-based standardization remains elusive. This non-systematic review analyzes the developmental trajectory of breast cancer surgery, examining the evolution and validation of oncoplastic techniques, standardized classification systems, applications in challenging clinical scenarios, and the current status of surgical education, emphasizing the pivotal role of professional societies in developing evidence-based educational initiatives to broaden access to these advanced surgical techniques.

肿瘤整形外科在乳腺癌治疗中的应用:发展和外科训练的回顾。
近几十年来,乳腺肿瘤整形手术(OBS)取得了重大进展,通过容积置换技术促进保乳手术(BCS)的增加,并在乳房切除术后通过容积置换实现立即重建,从而改变了乳腺癌(BC)的治疗。这种方法明显改善了接受肿瘤干预的患者的美容结果和与健康相关的生活质量指标。从霍尔斯特德的根治性乳房切除术到当代肿瘤整形技术,手术方法的进展构成了手术方法的基本范式转变。荟萃分析和前瞻性队列研究表明,与传统BCS和乳房切除术相比,肿瘤整形技术保持肿瘤安全性,显示出相当的局部复发率和无病生存(DFS)结果。肿瘤整形手术的多种分类系统已经建立在可量化指标的基础上,包括乳房体积切除百分比、手术复杂性指数和技术方法参数,为临床决策提供了基于证据的框架。乳房外科医生目前是乳腺癌多学科治疗的关键纽带,将优化的手术技术与多模式治疗方案结合起来,特别是全身治疗药物。新辅助化疗(NCT)方案的实施扩大了以前需要乳房切除术的病例的保乳指征,导致对选定患者的“极端肿瘤成形术”概念的发展。然而,全球范围内仍存在重大的实施障碍,主要与教育基础设施的限制和乳腺外科医生缺乏标准化的肿瘤整形外科培训课程有关。国际上出现了多种培训方法,包括基于模拟的学习、亚专业奖学金和外科住院医师项目的课程整合,尽管基于结果的标准化仍然难以捉摸。这篇非系统综述分析了乳腺癌手术的发展轨迹,检查了肿瘤整形技术的发展和验证,标准化分类系统,在具有挑战性的临床场景中的应用,以及外科教育的现状,强调了专业协会在发展循证教育计划以扩大这些先进外科技术的获取方面的关键作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.90
自引率
0.00%
发文量
0
期刊介绍: The Chinese Clinical Oncology (Print ISSN 2304-3865; Online ISSN 2304-3873; Chin Clin Oncol; CCO) publishes articles that describe new findings in the field of oncology, and provides current and practical information on diagnosis, prevention and clinical investigations of cancer. Specific areas of interest include, but are not limited to: multimodality therapy, biomarkers, imaging, tumor biology, pathology, chemoprevention, and technical advances related to cancer. The aim of the Journal is to provide a forum for the dissemination of original research articles as well as review articles in all areas related to cancer. It is an international, peer-reviewed journal with a focus on cutting-edge findings in this rapidly changing field. To that end, Chin Clin Oncol is dedicated to translating the latest research developments into best multimodality practice. The journal features a distinguished editorial board, which brings together a team of highly experienced specialists in cancer treatment and research. The diverse experience of the board members allows our editorial panel to lend their expertise to a broad spectrum of cancer subjects.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信